CompaniesInstratek

Instratek

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

0

As Collaborator

5

Total Enrollment

1,962

By Phase

NA: 3PHASE3: 2

By Status

COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT00982111
NCT00981058
Hover over trial bars to see details

Recent Trials

NCT06358742Collaborator
Evaluation of the Effect of Zinc Citrate Trihydrate Toothpaste on the Oral Plaque Microbiome
NACompleted
142 participants
Started: Jan 10, 2017 · Completed: May 19, 2017
NCT02857062Collaborator
To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin
NACompleted
34 participants
Started: Nov 23, 2016 · Completed: Feb 2, 2017
NCT02546258Collaborator
Evaluation of the Performance of a Fungal Nail Treatment on the Visual Signs of Onychomycosis
NACompleted
60 participants
Started: Aug 25, 2014 · Completed: Nov 21, 2014
NCT00981058Collaborator
First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin
PHASE3Completed
1,093 participants
Started: Jan 7, 2010 · Completed: May 30, 2024
NCT00982111Collaborator
First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin
PHASE3Completed
633 participants
Started: Nov 2, 2009 · Completed: Dec 23, 2020
Related Companies
Stryker
acquired
Instratek | Biotech Hunter | Biotech Hunter